Photos by William Castro Rodríguez / Partners In HealthField technician Gaby Merlin Contreras provides the new TB drug, Bedaquiline, to a patient in Lima, Peru. For the first time in 50 years, two new drugs are available to patients battling the most trenchant forms of tuberculosis. TB experts around the world, including those at Partners In Health, hope that Bedaquiline and Delamanid will deliver patients a quicker, less toxic cure than older drugs on the market. They will soon see whether their hope is justified. Through an effort called endTB, PIH and nongovernmental organizations Médecins sans Frontières and Interactive Research & Development are offering new treatment regimens that include Bedaquiline and Delamanid to more than 3,000 people
Jump to original –